Giant cell tumor of the bone (GCT) is a relatively uncommon tumor. It is characterized by the presence of multinucleated giant cells. GCT is a primary benign tumor but may evolve into a malignant tumor, usually after irradiation. We report a rare case of osteosarcoma arising ten years after the primary surgery for GCT without radiation. A 45-year-old woman presented with severe right knee pain after suffering contusion. Roentgenogram revealed a bone tumor in the lateral femoral condyle of the right knee. Histopathological examination demonstrated the features of GCT, and treatment consisted of curettage and bone grafting. Four months after the operation, multiple lung metastases of GCT occurred, which were treated by partial lobectomy. Ten years after the primary treatment, severe knee pain recurred. Roentgenogram and magnteic resonance imaging (MRI) demonstrated a destructive lesion in the lateral condyle of the right knee. Histopathological examination demonstrated a lacy pattern of osteoids and abnormal mitoses in the aggregated atypical mononuclear cells, indicating osteosarcoma. Despite above-knee amputation and chemotherapy, scapular and lung metastases developed and the patient died five months after above knee amputation. One may question whether the primary GCT contained some malignant cells. However, given the aggressiveness of the malignant tumor, this is unlikely. The recurrence of pain and aggravation of bone destruction many years after the primary treatment suggest malignant transformation of GCT. giant cell tumor; osteosarcoma; malignant transformation; long term
Giant cell tumor of the bone (GCT) is a relatively uncommon tumor. It is characterized by the presence of multinucleated giant cells. GCT is categorized as a primary benign tumor, but it is known that it may evolve into a malignant tumor. Although there are many reports of GCT in which the cases showed malignant transformation, most of those cases had been treated primarily by radiation. On the other hand, secondary malignant tumor without radiation therapy is very rare (Dahlin et al. 1970; Campanacci et al. 1987) .
We report a case of osteosarcoma arising ten years after the primary surgery for a benign GCT that was not treated with additional radiation therapy.
CASE REPORT
In 1994 a 45-year-old woman visited a clinic with gait disturbance due to right knee pain after suffering a contusion. A pathological fracture due to a bone tumor was noted in the lateral condyle of the right femur (Fig. 1) . A needle biopsy revealed the lesion have a GCT histologically, and class 2 cytologically. Then the patient was referred to our hospital. The lesion was curetted and autogeneous bone graft with artificial bone packing was performed. The histological diagnosis of the operative specimen was benign GCT (Fig. 2) .
Four months after the operation, dozens of metastatic tumors appeared in both lungs. Partial lobectomy was performed in the right lung. Histopathological examination demonstrated the metastatic tumors to be GCTs. In 2001, recurrent tumors were found in the right distal femur and both lungs, which were observed periodically without treatment because of the slow growth. The recurrent tumors of both lungs were irradiated in 2003 for control of the lesions.
In 2004 the patient was admitted to our clinic because she became unable to walk again due to severe right knee pain. Marked swelling and tenderness were noted. Laboratory data showed no inflammatory changes, while alkaline phosphatase (Al-P) was elevated to an abnormally high value (Fig. 4) . On MR images the osteolytic lesion extended into the soft tissue. The lesion was heterogeneous on T2-weighted images and clearly enhanced by Gadolinium enhancement (Fig. 5) . Macroscopically, specimens of open biopsy were soft, grayish-white. Light microscopy showed dense aggregation of mononuclear cells with highly anaplastic nucleus and mitoses more than 50 cells per 10 high-power fields (HPF).
Multinuclear giant cells were scattered throughout the specimens and osteoid formation was also remarkable (Fig. 6) . The tumor was diagnosed as high-grade osteosarcoma secondary to a benign GCT. Despite above-knee amputation and chemotherapy, scapular and lung metastases developed. The patient died five months after the above knee amputation.
DISCUSSION
GCT is known to be able to evolve into malignant tumor. McGrath (1972) classified such tumors into three types: primary, evolutionary and secondary. "Primary" is for tumors that are malignant from the outset, "evolutionary" for typical tumors that progress to a malignant form within a short period, and "secondary" for typical tumors that undergo sarcomatous changes after a relatively long symptom-free period, and usually developed after irradiation. In the literature the classification "evolutionary" has been applied for spontaneous malignant transformation of GCTs after a symptom-free period, whilst "secondary" has been used for post-irradiation malignancy. In reports of malignant transformation of GCTs the tumors were irradiated at the primary treatment.
On the other hand, malignant transformation without radiation therapy, as in our case, is very rare. Referring to the literatures, our case would be classified as evolutionary malignancy.
There have been 29 cases of malignancy in GCTs without radiation therapy in the English literature (Mnaymneh et al. 1964; Johnson et al. 1969; Dahlin et al. 1970; McGrath 1972; Nascimento et al. 1979; Sanerkin 1980; Sundaram et al. 1982; Boriani et al. 1986; Rock et al. 1986; Campanacci et al. 1987; Gitelis et al. 1989; Meis et al. 1989; Zhu et al. 1990; Hefti et al. 1992; Ortiz-Cruz et al. 1995; Brien et al. 1997; Sakkers et al. 1997; Mori et al. 2000; Marui et al. 2001; Bertoni et al. 2003; Grote et al. 2004 ). In those cases, 8 were primary and 21 were evolutionary malignancy. In the cases of evolutionary malignancy, the interval between the discovery of GCTs and malignant transformation ranged from 1.4 years to 25 years (average 9.9 years). Nine of the patients experienced malignant transformation more than 10 years after the initial diagnosis of GCTs. In this sense the 10 year interval of the present case would not be so uncommon. It is questionable about when such tumors underwent malignant transformation. In other words, there may have been malignant portions in the primary lesion. However, considering the aggressiveness of these tumors after malignant transformation, this would seem unlikely.
In the secondary malignant transformation in GCTs with or without radiation therapy, Rock et al. (1986) reported that fibrosarcoma developed three times more frequently than osteosarcoma. On the other hand, in the 21 cases of evolutionary malignancy in GCTs in the literature, histopathological diagnoses were fibrosarcoma in eight cases, osteosarcoma in seven, and malignant fibrous histiocytoma in six. No specific affinity was indicated concerning the histological type in evolutionary malignancy as compared with secondary malignancy. The histological examination in the present case demonstrated high-grade osteosarcoma. Hutter et al. (1962) and Dahlin et al. (1970) defined "malignant giant-cell tumor" as a sarcoma either juxtaposed to the zone of a typical giant-cell tumor or occurring at the site of the previous benign GCT. Although such a juxtaposition was not clearly noted in the present case, the osteosarcoma had definitely occurred at the site of the previous benign GCT. The fact that osteoclastic giant cells were abundant in the tumor, also confirmed the point.
The prognosis of secondary malignancy in GCTs has been reported to be poor. Nascimento et al. (1979) reported that the prognosis of secondary malignant GCT is worse than primary malignant GCT. However, the reported prognosis seemed to vary according to the generation. In the reports during the 1980s and earlier (Dahlin et al. 1970; Sanerkin 1980; Sundaram et al. 1982; Boriani et al. 1986 ), most patients with evolutionary malignancy in GCTs died 1 year or less after the malignancy had been discovered, while such patients survived 1 year or longer in the reports from the 1990s or later (Ortiz-Cruz et al. 1995; Sakkers et al. 1997; Mori et al. 2000; Marui et al. 2001; Bertoni et al. 2003; Grote et al. 2004) . Improvements in chemotherapy seem to contribute to the better prognosis. On the other hand, the prognosis after the appearance of malignancy is independ of the primary treatment, the histological type of the malignancy, or the duration between the onset of the primary benign GCT and the appearance of malignancy.
Although osteosarcoma arising from a benign GCT without radiation in the primary lesion is very rare, this should be considered as a differential diagnosis of recurrent benign GCT.
